The PAP Smear is a vital test used mostly in gynecological treatment for the early diagnosis of cervical cancer and its precursors. It has historically not been included in health heart diagnostics (HHD). In order to search for alterations or anomalies that might point to the existence of precancerous or cancerous cells, it entails removing cells from the cervix.
The PAP Smear is primarily intended to address cervical health, but it also plays a part in more general health conversations due to its potential indirect effects on women’s cardiovascular health. For example, the cardiovascular health of a woman can be influenced by her general health status, which includes her risk of many types of cancer. Research has demonstrated that heart failure and other cardiovascular disorders can become more common as a result of cancer and some of its therapies.